Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Curr Opin Cell Biol. 2013 Nov 28;0:32–43. doi: 10.1016/j.ceb.2013.11.001

Fig. 4. Orientation of GPCR-G protein complexes in a phospholipid membrane.

Fig. 4

Semi-empirical models of the complex formed between light-activated rhodopsin dimer and a Gt heterotrimer (A and B) [52] and the T4L-β2AR-Gs-nanobody complex (C) [48] were fitted into a 3D molecular envelope calculated from projections of negatively stained, bis[succinimidyl] 2,2,4,4-glutarate (DSG) crosslinked rhodopsin*-Gt complexes purified in lauryl maltose neopentyl glycol (LMNG). Fitting of the rhodopsin*-Gt model generated with the structure of inactive Gt (PDB code: 1GOT) leaves a significant unoccupied density above one of the rhodopsin molecules (A), which becomes occupied after a 30o hinge-like motion of the α-helical domain is applied (B). Though fitting the T4L-β2-adrenergic receptor-Gs-nanobody structure into our EM 3D map leaves sufficient space to accommodate a second molecule of this receptor, conformation of the G helical domain is inconsistent with our EM-density (C). Thus, the favored structure of the rhodopsin-Gt complex appears to be that shown in (B). Photoactivated rhodopsin (Rho*) that binds the C-terminal peptide derived from G and the T4L-β2-adrenergic receptor-nanobody molecule are both depicted in yellow. The second rhodopsin molecule in (A) and (B) is shown in gray. G, G, G are colored pink, dark cyan and dark blue, respectively.